SomaLogic Publishes Details of Upcoming Lung Cancer Test, New Proteomics Discovery Platform
June 15, 2010
SomaLogic Publishes Details of Upcoming Lung Cancer Test, New Proteomics Discovery Platform
The two studies, published in Nature Precedings, are part of an effort by the Boulder, Colo.-based firm to gain more attention for the role its technology platform can play in diagnostics development.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- UK Dx Firm Avacta Readies High-Density 'Affimer' Protein Array Platform for 2014 Debut
March 12, 2013 / BioArray News - Somalogic Publishes Validation Study on 13-Protein Dx for Detection of Mesothelioma
October 5, 2012 / ProteoMonitor - Somalogic Teams with HUNT for 2,000-Patient Validation Study of Cardiovascular Biomarkers
April 13, 2012 / ProteoMonitor - NYU, Somalogic Present Data on Protein Biomarker Test for Mesothelioma
April 8, 2011 / ProteoMonitor - Proteomics Firms Net More than $8.75M in IRS Funds; Bulk of Awards Aimed at Diagnostics Work
November 5, 2010 / ProteoMonitor